XONELITY Trademark

Trademark Overview


On Tuesday, January 12, 2021, a trademark application was filed for XONELITY with the United States Patent and Trademark Office. The USPTO has given the XONELITY trademark a serial number of 90460424. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 27, 2024. This trademark is owned by Alkermes Pharma Ireland Limited. The XONELITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases including schizophrenia, depression, major depressive disorder, treatment resistant depression, bipolar depression, bipolar disorder,mitigation of weight gain, metabolic diseases and dyslipidemia
xonelity

General Information


Serial Number90460424
Word MarkXONELITY
Filing DateTuesday, January 12, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 31, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases including schizophrenia, depression, major depressive disorder, treatment resistant depression, bipolar depression, bipolar disorder,mitigation of weight gain, metabolic diseases and dyslipidemia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlkermes Pharma Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDubin 4
IE

Party NameAlkermes Pharma Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDubin 4
IE

Trademark Events


Event DateEvent Description
Friday, January 15, 2021NEW APPLICATION ENTERED
Thursday, July 22, 2021ASSIGNED TO EXAMINER
Monday, April 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 11, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 31, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 31, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2022SOU EXTENSION 1 GRANTED
Tuesday, October 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 5, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 5, 2022SOU EXTENSION 1 FILED
Thursday, April 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 10, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 10, 2022SOU EXTENSION 2 FILED
Tuesday, March 28, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 28, 2023SOU EXTENSION 3 FILED
Tuesday, March 28, 2023SOU EXTENSION 3 GRANTED
Thursday, October 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 12, 2023SOU EXTENSION 4 FILED
Thursday, October 12, 2023SOU EXTENSION 4 GRANTED
Saturday, October 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 27, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 10, 2022SOU EXTENSION 2 GRANTED
Wednesday, October 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED